Moreover, we observed that MAP17 prevents the cytoprotective activation of NFκB and autophagy induced by bortezomib (Figure 6C, Supplementary Figure S4B) in sarcoma cell lines, a finding that has been reported previously for breast tumor cells [29]. This evidence concerns the gene NFKB1 and breast neoplasm.